Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026)
Natera's (NTRA) quarterly Non-Current Deferred Tax Liability came in at $701000.0 in Q1 2026, little changed on a QoQ basis from $701000.0 in Q4 2025.
Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Natera (NTRA) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $701000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $701000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $701000.0 (changed N/A YoY) and the FY2025 annual result came in at $701000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability held at $701000.0 in Q1 2026, from $701000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $701000.0 in Q4 2025 to a low of $701000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 701,000.00 |
| Jun 30, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |